(2015). Oral bacitracin: A consideration for suppression of intestinal vancomycin-resistant enterococci (VRE) and for VRE bacteremia from an apparent gastrointestinal tract source.
Chicago Style (17th ed.) CitationOral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-resistant Enterococci (VRE) and for VRE Bacteremia from an Apparent Gastrointestinal Tract Source. 2015.
MLA (8th ed.) CitationOral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-resistant Enterococci (VRE) and for VRE Bacteremia from an Apparent Gastrointestinal Tract Source. 2015.
Warning: These citations may not always be 100% accurate.